Physician profile
Robert Brautigan
NPI 1932277118
$5,728.27
in general payments reported to CMS, 2019-2025
31 companies · $572 in 2025
The $572 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $886 · 2020: $145 · 2021: $280 · 2022: $345 · 2023: $120 · 2024: $3,379 · 2025: $572.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,392 · Travel and Lodging: $1,679.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,392.17 |
| Travel and Lodging | $1,679.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $2,604.94 | 2024-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $830.74 | 2022-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Allergan, INC. | $723.41 | 2019-2020 | |
| Acera Surgical, INC. | $150.43 | 2023-2025 | Restrata Wound Matrix |
| Alexion Pharmaceuticals, INC. | $133.33 | 2021 | |
| Teleflex LLC | $128.92 | 2019-2025 | Deknatel, Titan Sgs Standard Gastric Stapler |
| Janssen Pharmaceuticals, INC | $124.98 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $122.19 | 2022 | |
| Ethicon US, LLC | $113.94 | 2019-2023 | Echelon Endopath, Stratafix, Echelon Flex |
| Chiesi USA, INC. | $105.16 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $69.22 | 2022 | |
| Conmed Corporation | $68.75 | 2024 | Airseal |
| Vertex Pharmaceuticals Incorporated | $63.81 | 2024-2025 | |
| Csl Behring | $55.21 | 2020-2022 | |
| Abbvie INC. | $51.79 | 2021 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $48.48 | 2024 | |
| Octapharma USA, INC. | $41.38 | 2025 | Fibryga |
| Innocoll Pharmaceuticals Limited | $37.39 | 2021 | |
| Davol INC. | $35.38 | 2019-2021 | |
| Medtronic, INC. | $27.32 | 2025 | Maxtack |
| Solventum Corporation | $26.92 | 2025 | Prevena, V.A.C.Ulta, V.A.C.Instill |
| Integra Lifesciences Corporation | $24.21 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Convatec INC. | $20.44 | 2024 | |
| Mimedx Group, INC. | $17.22 | 2025 | |
| Smith+Nephew, INC. | $16.15 | 2024 | Collagenase Santyl |
| Kowa Pharmaceuticals America, INC. | $16.09 | 2023 | Seglentis |
| Avanos Medical | $14.92 | 2019 | |
| Heron Therapeutics, INC. | $14.66 | 2021 | |
| Mallinckrodt Enterprises LLC | $14.09 | 2019 | |
| Shire North American Group INC | $14.01 | 2019 | |
| Merck Sharp & Dohme LLC | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brautigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.